scorecardresearch
Add as a preferred source on Google
Tuesday, January 6, 2026
TopicSun Pharma

Topic: Sun Pharma

Gujarat to get Rs 150 cr leadership institute—Modi’s brainchild, backed by India’s top Industry leaders

Former finance secretary Hashmukh Adhia has been appointed the chairman of the executive committee of School of Ultimate Leadership (SOUL).

US drug regulator halts Sun Pharma trials on dermatological drug

Sun Pharma, India's largest drugmaker by revenue, acquired deuruxolitinib when it bought US-based Concert Pharmaceuticals for $576 million earlier this year.

US FDA asks India’s Sun Pharma to halt trials on experimental dermatological drug

Sun Pharma said FDA has also stated that patients with alopecia areata on 12 mg dose of the drug deuruxolitinib should discontinue its use, Sun Pharma said.

On Camera

A 2-hour op, precise extradition—what Maduro’s capture tells us about modern US military

Despite multiple agencies being involved, the US could maintain a clear chain of command. This is something India should consider too, as it defines the theatre command structures.

Trump threatens India with fresh tariffs on Russian oil, calls PM Modi a ‘good guy’

The latest comment comes as New Delhi and Washington have yet to sign a trade agreement. India’s purchase of Russian oil has reduced, but Moscow remains top source for crude.

Pakistan defence exports at all-time high, ‘contracts’ worth $10 bn inked across globe in 2025

Export arrangements entered with nations ranging from Azerbaijan to Zimbabwe, highlighting both geographic reach & growing contours of Pakistan’s defence export composition.

A year-end Mea Culpa in National Interest—The Army-Islam combo doesn’t kill democracy

Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.